Janux Therapeutics, Inc. (JANX) Commences Patient Dosing of JANX011 in Autoimmune Trial

wccwcc
Mar 2, 2026 - 09:50
 0  2
Janux Therapeutics, Inc. (JANX) Commences Patient Dosing of JANX011 in Autoimmune Trial

What's Your Reaction?

like like 0
dislike dislike 0
love love 0
funny funny 0
angry angry 0
sad sad 0
wow wow 0